By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Radius Health 

950 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-551-4000 Fax: 617-551-4701


SEARCH JOBS

Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.

Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis market.


YEAR FOUNDED:

October 3, 2003

LEADERSHIP:

Founders: John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt and John T. Potts

CEO: Robert Ward

CMO (Medical): Lorraine Fitzpatrick

CFO: Nick Harvey

CSO (Scientific): Gary Hattersley

JOBS:

Please click here for Radius Health job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@radiuspharm.com
Ownership: Public

Web Site: Radius Health
Employees:
Symbol: RDUS
 



Industry
Pharmaceutical






Company News
Radius Health (RDUS) Reports Fourth Quarter And Full Year 2016 Financial And Operating Results 2/24/2017 8:20:47 AM
Radius Health (RDUS) Release: Mayo Clinic Proceedings Publishes Positive Results From The Activextend Clinical Trial Of Abaloparatide-SC In Postmenopausal Women With Osteoporosis 2/1/2017 7:22:37 AM
Radius Health (RDUS) To Announce Fourth Quarter And Full Year 2016 Financial Results, Host Conference Call And Live Webcast On February 23, 2017 1/31/2017 7:40:16 AM
Radius Health (RDUS) Presents Positive Phase I Data For Investigational Drug RAD1901 At The San Antonio Breast Cancer Symposium (SABCS) 2016 12/8/2016 7:23:19 AM
Radius Health (RDUS) Reports Third Quarter 2016 Financial And Operating Results 11/3/2016 10:55:53 AM
Radius Health (RDUS) To Announce Third Quarter 2016 Financial Results, Host Conference Call And Live Webcast On November 3, 2016 10/12/2016 8:54:42 AM
Radius Health (RDUS) Presents Abaloparatide Transdermal Patch Development Program At American Society For Bone And Mineral Research (ASBMR) 2016 Annual Meeting 9/20/2016 10:09:47 AM
Radius Health (RDUS) Announces Publication Of Additional Positive Results From The Phase 3 ACTIVE Trial Of Abaloparatide-SC In JBMR 9/19/2016 9:50:15 AM
Radius Health (RDUS) Announces Three Presentations On RAD1901 At The San Antonio Breast Cancer Symposium (SABCS) December 6-10, 2016 8/30/2016 8:06:27 AM
3 High-Risk, High-Reward Biotech Stocks 8/24/2016 6:15:40 AM
12345678910...
//-->